Indegene Limited (BSE: INDGN.BO) Stock Competitors & Peer Comparison
See INDGN.BO's competitors and their performance on the BSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for INDGN.BO and its BSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INDGN.BO | ₹514.90 | +0.08% | 124.1B | 30.92 | ₹16.65 | +0.44% |
| IKS.NS | ₹1,848.90 | +3.74% | 310.2B | 43.61 | ₹42.40 | N/A |
| IKS.BO | ₹1,848.95 | +3.73% | 310.2B | 43.61 | ₹42.40 | N/A |
| SAGILITY.NS | ₹43.40 | -5.61% | 203.2B | 18.95 | ₹2.29 | +0.12% |
| SAGILITY.BO | ₹43.43 | -5.57% | 202.1B | 20.24 | ₹2.15 | +0.12% |
| INDGN.NS | ₹515.15 | +0.09% | 124.1B | 30.94 | ₹16.65 | +0.44% |
| MEDIASSIST.NS | ₹358.00 | +0.15% | 26.7B | 25.26 | ₹14.17 | N/A |
Stock Comparison
Inventurus Knowledge Solutions Ltd. (NSE: IKS.NS)
INDGN.BO vs IKS.NS Comparison August 2026
Indegene Limited (BSE: INDGN.BO) plays a significant role within the Healthcare sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDGN.BO stands at 124.1B. In comparison, IKS.NS has a market cap of 310.2B. Regarding current trading prices, INDGN.BO is priced at ₹514.90 on the BSE, while IKS.NS trades at ₹1,848.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDGN.BO currently has a P/E ratio of 30.92, whereas IKS.NS's P/E ratio is 43.61. In terms of profitability, INDGN.BO's ROE is +0.14%, compared to IKS.NS's ROE of +0.32%. Regarding short-term risk, INDGN.BO is more volatile compared to IKS.NS. This indicates higher risk in terms of short-term price fluctuations for INDGN.BO.Check IKS.NS's competition here